Diabetes Pill Given a Coin Flip’s Chance of Approval Ahead of FDA Meeting

(Bloomberg) -- Investors may know by the end of Thursday if Lexicon Pharmaceuticals Inc. will have a second drug ready to reach the market or if the small-cap biotech company needs to go back to th...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.